Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD22 | P20273 | 9/20 | 0.37 |
| ▸ | SELP | P16109 | 1/20 | 0.36 |
| ▸ | NANP | Q8TBE9 | 1/20 | 0.35 |
| ▸ | SIGLEC7 | Q9Y286 | 4/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13948842 | 0.97 | CD22 (0.37) | CD22SELPNANP | |
| SCHEMBL12341458 | 0.95 | NANP (0.38) | CD22SELPNANP | |
| SCHEMBL13948847 | 0.89 | CD22 (0.34) | CD22SELP | |
| SCHEMBL13948843 | 0.88 | CD22 (0.32) | CD22SELP | |
| SCHEMBL13402333 | 0.88 | CD22 (0.38) | CD22NANP | |
| SCHEMBL13948846 | 0.86 | CD22 (0.32) | CD22SELPNANP | |
| SCHEMBL13402334 | 0.86 | CD22 (0.38) | CD22NANP | |
| SCHEMBL12341459 | 0.85 | NANP (0.39) | CD22NANP | |
| SCHEMBL12341472 | 0.84 | CD22 (0.34) | CD22SELPNANP | |
| SCHEMBL12341463 | 0.83 | CD22 (0.33) | CD22SELPNANP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100081791-A1 | GLYCOPEGYLATED FACTOR IX | NOVO NORDISK A/S (DK) | 2010-04-01 | — | — | US | disclosed |
| US-20100041872-A1 | GLYCEROL LINKED PEGYLATED SUGARS AND GLYCOPEPTIDES | NOVO NORDISK A/S (DK) | 2010-02-18 | — | — | US | disclosed |
| US-20090305967-A1 | GLYCOPEGYLATED FACTOR VII AND FACTOR VIIA | NOVO NORDISK A/S (DK) | 2009-12-10 | — | — | US | disclosed |
| US-20090124544-A1 | COMPOSITIONS AND METHODS FOR THE PREPARATION OF PROTEASE RESISTANT HUMAN GROWTH HORMONE GLYCOSYLATION MUTANTS | NEOSE TECHNOLOGIES ,INC. A DELAWARE CORPORATION | 2009-05-14 | — | — | US | disclosed |
| US-20080300173-A1 | Branched Peg Remodeling and Glycosylation of Glucagon-Like Peptides-1 [Glp-1] | NOVO NORDISK A/S (DK) | 2008-12-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090305967-A1 | GLYCOPEGYLATED FACTOR VII AND FACTOR VIIA | F7, F13B, F13A1 | CD22 1638/4885SELP 198/4885NANP 431/4885 |
| US-20100081791-A1 | GLYCOPEGYLATED FACTOR IX | F9, F13A1, F13B | CD22 390/4885SELP 112/4885NANP 156/4885 |
| US-20080300173-A1 | Branched Peg Remodeling and Glycosylation of Glucagon-Like Peptides-1 [Glp-1] | GLP1R, GIPR, IAPP | CD22 433/4885SELP 605/4885NANP 896/4885 |
| US-20100041872-A1 | GLYCEROL LINKED PEGYLATED SUGARS AND GLYCOPEPTIDES | UGCG, B3GAT3, UGGT1 | CD22 367/4885SELP 270/4885NANP 306/4885 |
| US-20090124544-A1 | COMPOSITIONS AND METHODS FOR THE PREPARATION OF PROTEASE RESISTANT HUMAN GROWTH HORMONE GLYCOSYLATION MUTANTS | GHITM, PTMS, GHRHR | CD22 2233/4885SELP 2771/4885NANP 386/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.